Skip to main content
MedPathMedPath Home
Clinical Trials/JPRN-UMIN000012659
JPRN-UMIN000012659
Completed
N/A

Stentless mitral valve replacement using autologous pericardium study - Stentless mitral valve replacement using autologous pericardium study

Sakakibara Heart Institute0 sites25 target enrollmentDecember 24, 2013
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsMitral regurgitation

Overview

Phase
N/A
Intervention
Not specified
Conditions
Mitral regurgitation
Sponsor
Sakakibara Heart Institute
Enrollment
25
Status
Completed
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 24, 2013
End Date
January 31, 2020
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • •1\. Active malignancy except for in situ cancer 2\. Dialysis 3\. Participating in other trials 4\. Myocardial infarction in the last 6 months 5\. Stroke in the last 6 months 6\. Previous percutaneous coronary stenting in a month before surgery 7\. Concomitant procedures other than tricuspid valve repair, maze operation and pulmonary vein isolation. 8\. Severe left ventricular dysfunction (ejection fraction less than 0\.30\) 9\. When excellent outcomes and prognosis are expected with standard prosthetic mitral valve replacement 10\. When a principal investigator deems a patient inappropriate as a trial subject

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
N/A
Stentless mitral valve replacement using autologous pericardium studyMitral valve disease
JPRN-UMIN000021445Keio University School of Medicine30
Suspended
N/A
Stentless mitral valve replacement using autologous pericardium studyMitral regurgitation
JPRN-jRCT1032180087Shimokawa Tomoki25
Completed
N/A
Mitral valve surgery using stentress bioprosthesis made from autologous pericardiumMitral insufficiency
JPRN-UMIN000017201CV suregry5
Suspended
N/A
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid TMVR System in Patients With Severe Symptomatic Mitral Regurgitation (APOLLO)Moderate-to-severe or severe symptomatic mitral regurgitation
JPRN-UMIN000038202Medtronic Japan Co., Ltd1,350
Recruiting
N/A
Transcatheter Mitral Valve Replacement with the Medtronic Intrepid* TMVR Transfemoral System in patients with severe symptomatic mitral regurgitation - APOLLO-EU Trialleaking heart valvemitral regurgitation10046973
NL-OMON56063Medtronic B.V.24